ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression

Journal:

JAMA Psychiatry

Published:

2025-09-11

DOI:

10.1001/jamapsychiatry.2025.2416

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
Denovo Biopharma, United States of America (USA)	8.000000	0.53
Beijing Anding Hospital, Capital Medical University, China	2.000000	0.13
SG Research, United States of America (USA)	1.000000	0.07
Huzhou No.3 Hospital, China	1.000000	0.07
Wuxi Mental Health Center, China	1.000000	0.07
The University of Texas at Austin (UT Austin), United States of America (USA)	1.000000	0.07
Bio Behavioral Health, United States of America (USA)	1.000000	0.07

Interested in Pharmacology and Pharmaceutical Sciences?